Isofol Medical AB’s (publ) Nomination Committee proposes New Chair of the Board
GOTHENBURG, Sweden, April 8, 2022 – The Nomination Committee of Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), proposes that Jan Törnell is elected Chair of the Board of Directors of the company at the Annual General Meeting on May 19, 2022. The current Chair Pär-Ola Mannefred has declined re-election.Jan Törnell has many years of experience from the international pharmaceutical industry, having served as Vice President of Global Strategy at AstraZeneca Oncology & Infection, among other roles. He currently consults in different pharmaceutical projects and serves on several boards in